Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Paramount Bed Holdings Co's enterprise value is $857.7 Mil.
Paramount Bed Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $62.7 Mil. Therefore, Paramount Bed Holdings Co's EV-to-EBITDA for today is 13.67.
The historical rank and industry rank for Paramount Bed Holdings Co's EV-to-EBITDA or its related term are showing as below:
PBHDF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.09 Med: 8.6 Max: 17.29
Current: 14.42
During the past 13 years, the highest EV-to-EBITDA of Paramount Bed Holdings Co was 17.29. The lowest was 4.09. And the median was 8.60.
PBHDF's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 13.845
vs PBHDF: 14.42
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Paramount Bed Holdings Co (OTCPK:PBHDF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Paramount Bed Holdings Co's PE Ratio (TTM) for today is calculated as:
Paramount Bed Holdings Co's share price for today is $19.74.
Paramount Bed Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.289.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's EV-to-EBITDA falls into.
Paramount Bed Holdings Co's current Enterprise Value is $857.7 Mil.
Paramount Bed Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $62.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co (PBHDF) has a EV-to-EBITDA of 13.67 as of Jul. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Paramount Bed Holdings Co. This is 59% above median its historical median of 8.60. Over the past decade, Paramount Bed Holdings Co's EV-to-EBITDA has ranged from 4.09 to 17.29.
Is Paramount Bed Holdings Co's EV-to-EBITDA too high?
Paramount Bed Holdings Co's current EV-to-EBITDA of 13.67 is 59% above median its 10-year median of 8.60. Over the past 10 years, this metric has ranged from a low of 4.09 to a high of 17.29. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.85. Paramount Bed Holdings Co's value of 13.67 is 1.3% below this industry median. Overall, Paramount Bed Holdings Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's EV-to-EBITDA compare to ISRG and BDX?
Paramount Bed Holdings Co's EV-to-EBITDA of 13.67 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBITDA is 13.85. Paramount Bed Holdings Co's value of 13.67 is 1.3% below this benchmark. Historically, Paramount Bed Holdings Co's own EV-to-EBITDA has ranged from 4.09 to 17.29 over the past decade. While the company's 10-year median is 8.60 vs. the industry median of 13.85, Paramount Bed Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.85, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paramount Bed Holdings Co's current EV-to-EBITDA of 13.67 is 1.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Paramount Bed Holdings Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current EV-to-EBITDA is 13.67, which is 59% above median its own 10-year median of 8.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (PBHDF) has a current EV-to-EBITDA of 13.67. The stock's GF Value™ is $16.33, compared to a current price of $19.74 — trading 20.9% above its estimated fair value. The current EV-to-EBITDA is 13.67, which is 59% above median its 10-year median of 8.60 and 1.3% below the Medical Devices & Instruments industry median of 13.85. Paramount Bed Holdings Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Paramount Bed Holdings Co (PBHDF), the current EV-to-EBITDA is 13.67 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (PBHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of $19.74 is trading 20.9% above its estimated GF Value™ of $16.33.
Key valuation signals for PBHDF:
EV-to-EBITDA: 13.67 (59% above median its 10-year median of 8.60)
GF Value™: $16.33 vs. price of $19.74 (20.9% above fair value)
Industry Position: 1.3% below the Medical Devices & Instruments median
No single metric tells the full story. See the PBHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
90GF Score
Get the complete analysis for PBHDF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBHDF has been successfully added to your 
